Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(9 sites)
Japan
Sendai Medical Center, Sendai, Miyagi Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka University of Fukui Hospital, Fukui Tsuchiura Kyodo General Hospital, Ibaraki Osaka University Hospital, Osaka Jichi Medical University Hospital, Tochigi Jikei University Hospital, Tokyo Keio University Hospital, Tokyo Wakayama Medical University Hospital, Wakayama Age range
18 Years and older
Last updated October 2024